Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012124964> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2012124964 endingPage "530" @default.
- W2012124964 startingPage "525" @default.
- W2012124964 abstract "Summary: Purpose: Vigabatrin (VGB) has been shown to cause visual field constriction and other forms of mild visual dysfunction. We determined the safety of continuing VGB therapy in patients who had received prolonged treatment (>2 years) with the drug by serially monitoring changes in visual function over a 1‐year period of continued therapy. We also followed up patients who discontinued VGB to see whether alternative therapies are effective. Methods: Fifteen of 17 patients who continued VGB therapy had visual‐function testing (visual acuity, color vision, kinetic and static perimetry) every 3 months for 1 year. Eighteen patients who discontinued VGB were given alternative antiepileptic drugs (AEDs); their seizure responses were measured after ≥3 months of treatment. Results: Patients continuing VGB showed no worsening of visual acuity, color vision, or visual‐field constriction beyond that measured in the initial test. Many patients who discontinued VGB had good seizure control with either newer or previously unsuccessful AEDs. Conclusions: For patients who have an excellent response to VGB and only mild visual changes, continued therapy may be safe with close visual monitoring. Patients who do not have a significant reduction in seizures or who experience considerable visual dysfunction with VGB may respond well to alternative therapies." @default.
- W2012124964 created "2016-06-24" @default.
- W2012124964 creator A5003987902 @default.
- W2012124964 creator A5024433871 @default.
- W2012124964 creator A5062439343 @default.
- W2012124964 creator A5062520786 @default.
- W2012124964 creator A5066854286 @default.
- W2012124964 creator A5071944374 @default.
- W2012124964 date "2001-04-20" @default.
- W2012124964 modified "2023-10-16" @default.
- W2012124964 title "Visual Function is Stable in Patients Who Continue Long-Term Vigabatrin Therapy: Implications for Clinical Decision Making" @default.
- W2012124964 cites W2005689818 @default.
- W2012124964 cites W2038749218 @default.
- W2012124964 cites W2043354111 @default.
- W2012124964 cites W2070403944 @default.
- W2012124964 cites W2080221650 @default.
- W2012124964 cites W2085050047 @default.
- W2012124964 cites W2095185628 @default.
- W2012124964 cites W2116602570 @default.
- W2012124964 cites W2146722689 @default.
- W2012124964 cites W2155441370 @default.
- W2012124964 cites W2162594619 @default.
- W2012124964 cites W2164373058 @default.
- W2012124964 cites W3188623826 @default.
- W2012124964 cites W4251578348 @default.
- W2012124964 doi "https://doi.org/10.1046/j.1528-1157.2001.49299.x" @default.
- W2012124964 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11440348" @default.
- W2012124964 hasPublicationYear "2001" @default.
- W2012124964 type Work @default.
- W2012124964 sameAs 2012124964 @default.
- W2012124964 citedByCount "35" @default.
- W2012124964 countsByYear W20121249642012 @default.
- W2012124964 countsByYear W20121249642014 @default.
- W2012124964 countsByYear W20121249642023 @default.
- W2012124964 crossrefType "journal-article" @default.
- W2012124964 hasAuthorship W2012124964A5003987902 @default.
- W2012124964 hasAuthorship W2012124964A5024433871 @default.
- W2012124964 hasAuthorship W2012124964A5062439343 @default.
- W2012124964 hasAuthorship W2012124964A5062520786 @default.
- W2012124964 hasAuthorship W2012124964A5066854286 @default.
- W2012124964 hasAuthorship W2012124964A5071944374 @default.
- W2012124964 hasBestOaLocation W20121249641 @default.
- W2012124964 hasConcept C118487528 @default.
- W2012124964 hasConcept C118552586 @default.
- W2012124964 hasConcept C141071460 @default.
- W2012124964 hasConcept C187212893 @default.
- W2012124964 hasConcept C2775858608 @default.
- W2012124964 hasConcept C2776058522 @default.
- W2012124964 hasConcept C2778186239 @default.
- W2012124964 hasConcept C2778257484 @default.
- W2012124964 hasConcept C2780837902 @default.
- W2012124964 hasConcept C71924100 @default.
- W2012124964 hasConceptScore W2012124964C118487528 @default.
- W2012124964 hasConceptScore W2012124964C118552586 @default.
- W2012124964 hasConceptScore W2012124964C141071460 @default.
- W2012124964 hasConceptScore W2012124964C187212893 @default.
- W2012124964 hasConceptScore W2012124964C2775858608 @default.
- W2012124964 hasConceptScore W2012124964C2776058522 @default.
- W2012124964 hasConceptScore W2012124964C2778186239 @default.
- W2012124964 hasConceptScore W2012124964C2778257484 @default.
- W2012124964 hasConceptScore W2012124964C2780837902 @default.
- W2012124964 hasConceptScore W2012124964C71924100 @default.
- W2012124964 hasIssue "4" @default.
- W2012124964 hasLocation W20121249641 @default.
- W2012124964 hasLocation W20121249642 @default.
- W2012124964 hasOpenAccess W2012124964 @default.
- W2012124964 hasPrimaryLocation W20121249641 @default.
- W2012124964 hasRelatedWork W1998214697 @default.
- W2012124964 hasRelatedWork W2018972558 @default.
- W2012124964 hasRelatedWork W2041291630 @default.
- W2012124964 hasRelatedWork W2042103292 @default.
- W2012124964 hasRelatedWork W2053488878 @default.
- W2012124964 hasRelatedWork W2056623102 @default.
- W2012124964 hasRelatedWork W2163662781 @default.
- W2012124964 hasRelatedWork W2404581573 @default.
- W2012124964 hasRelatedWork W2417743108 @default.
- W2012124964 hasRelatedWork W3204609523 @default.
- W2012124964 hasVolume "42" @default.
- W2012124964 isParatext "false" @default.
- W2012124964 isRetracted "false" @default.
- W2012124964 magId "2012124964" @default.
- W2012124964 workType "article" @default.